Page last updated: 2024-09-05

paromomycin and Hepatic Encephalopathy

paromomycin has been researched along with Hepatic Encephalopathy in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (50.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernauer, E; Finsterer, J	1
Brogden, RN; Gillis, JC	1
Celle, G; De Leo, C; Eftimiadi, C; Rovida, S; Schito, GC; Sukkar, GS; Testa, R	1
Berk, DP; Chalmers, T	1

Reviews

1 review(s) available for paromomycin and Hepatic Encephalopathy

Article	Year
Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs, 1995, Volume: 49, Issue:3 Topics: Diarrhea; Diverticulum, Colon; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Neomycin; Paromomycin; Rifamycins; Rifaximin	1995

Article

Year

Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria.

Drugs, 1995, Volume: 49, Issue:3

Topics: Diarrhea; Diverticulum, Colon; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Neomycin; Paromomycin; Rifamycins; Rifaximin

1995

Other Studies

3 other study(ies) available for paromomycin and Hepatic Encephalopathy

Article	Year
Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy. Metabolic brain disease, 2005, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Antiparkinson Agents; Benzothiazoles; Brain; Chronic Disease; Dipeptides; Evoked Potentials, Visual; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Paromomycin; Pramipexole; Recovery of Function; Thiazoles; Treatment Outcome; Vision Disorders	2005
A non-absorbable rifamycin for treatment of hepatic encephalopathy. Drugs under experimental and clinical research, 1985, Volume: 11, Issue:6 Topics: Absorption; Adult; Aged; Ammonia; Colon; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Paromomycin; Rifamycins; Rifaximin	1985
Deafness complicating antibiotic therapy of hepatic encephalopathy. Annals of internal medicine, 1970, Volume: 73, Issue:3 Topics: Adult; Aged; Alcoholism; Ascites; Audiometry; Creatinine; Deafness; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Paromomycin; Time Factors	1970